Skip to main content
. Author manuscript; available in PMC: 2015 Feb 17.
Published in final edited form as: J Pediatr. 2002 Sep;141(3):327–334. doi: 10.1067/mpd.2002.126301

Table II. Cumulative 5-year incidence of cardiac complications in the neonatal cohort (group II).

Complication 5-Year incidence

HIV-infected (n = 93) HIV-uninfected (n = 463)


No. of events % 95% CI No. of events % 95% CI P value (from log-rank test)
↓Fractional shortening (≤25%) 8 10.7 3.7, 17.8 13 3.1 1.4, 4.7 .01
↓Fractional shortening (19%–25%) 7 9.3 2.7, 15.9 12 2.9 1.3, 4.5 .02
↓Fractional shortening (<19%) 1 1.4 0.0, 4.1 1 0.2 0.0, 0.6 .23
↑LVED dimension (Z score >2) 7 10.3 3.0, 17.6 8 2.1 0.6, 3.5 .007
↑LVED dimension (Z score >3) 0 0.0 2 0.6 0.0, 1.4 .51
↑LVES dimension (Z score >2) 30 41.7 28.8, 54.7 52 17.1 12.0, 22.2 .001
↑LVES dimension (Z score >3) 10 14.1 5.9, 22.3 7 1.8 0.5, 3.1 .001
Cardiomegaly (radiography) 29 51.3 33.5, 69.1
Pericardial effusion (≥5 mm maximal diameter) 3 5.4 0.0, 7.1 2 0.9 0.0, 2.1 .05
↑Heart rate (echocardiogram) (Z score >2) 57 78.7 67.7, 89.7 78 32.2 23.6, 40.7 .001
↑Heart rate (echocardiogram) (Z score >3) 23 35.5 22.2, 48.7 17 8.3 2.5, 14.2 .001
CHF 4 5.1 0.2, 10.0 1 0.2 0.0, 0.7 < .001
CHF and/or cardiac medications 9 13.6 4.8, 22.3 2 0.5 0.0, 1.2 .001
Cardiac impairment 12 17.7 8.1, 27.3 2 0.5 0.0, 1.2 < .001